The present invention provides a compound of formula I:
wherein R
1
, R
2
, R
3
, R
4
, and R
5
are as defined herein. The present invention also provides pharmaceutical compositions and methods using such compositions for treating a caspase-mediated diseases and processes for preparing the compounds of the invention.
3-[2-(3-Amino-2-oxo-2H-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
申请人:VERTEX PHARMACEUTICALS INCORPORATED
公开号:EP2412707A2
公开(公告)日:2012-02-01
The present invention provides a compound of formula I:
wherein R1, R2, R3, R4, and R5 are as defined herein. The present invention also provides pharmaceutical compositions and methods using such compositions for treating a caspase-mediated diseases and processes for preparing the compounds of the invention.
本发明提供了一种式 I 的化合物:
其中 R1、R2、R3、R4 和 R5 如本文所定义。本发明还提供了治疗卡巴酶介导的疾病的药物组合物和使用这种组合物的方法,以及制备本发明化合物的工艺。
3-[2-(3-AMINO-2-OXO-2H-PYRIDIN-1-YL)-ACETYLAMINO]-4-OXO-PENTANOIC ACID DERIVATIVES AND THEIR USE AS CASPASE INHIBITORS
申请人:VERTEX PHARMACEUTICALS INCORPORATED
公开号:EP1631549A2
公开(公告)日:2006-03-08
US7960415B2
申请人:——
公开号:US7960415B2
公开(公告)日:2011-06-14
[EN] CASPASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE CASPASE ET UTILISATIONS
申请人:VERTEX PHARMA
公开号:WO2004106304A2
公开(公告)日:2004-12-09
The present invention provides a compound of formula (I), wherein R1, R6C(O)-, HC(O)-, R6SO2-, R6OC(O)-, (R6)2NC(O)-, (R6) (H) NC (O)-, R6C (O) C (O) -, R6-, (R6) 2NC (O) C (O)-, R6 (H) NC (O) C (O)-, or R6OC (O) C (O)-; R2 is hydrogen, CF3, -halo, -OR7, -NO2, -OCF3, -CN, or R8; R3 is hydrogen or (C1-C4) -aliphatic-; R4 is -COOH or -COOR8; R5 is -CH2F or -CH2O-2, 3, 5, 6-tetrafluorophenyl. The present invention also provides pharmaceutical compositions and methods using such compositions for treating a caspase-mediated diseases and processes for preparing the compounds of the invention.